External Control Arm

RWE Methods · External Controls

External Control Arms

14 to 15 October 2026Hampton Inn by Hilton, Boston Seaport, USA

An external control arm builds a comparator from real-world or historical data, when a randomized control arm is not feasible or ethical.

External controls, and the real-world data behind them, are on the agenda at RWE Connect 2026 in Boston.

Get the RWE Study Methods Primer
A plain-English guide to the core methods. Instant download, three fields.










    Free. Instant download. No obligation.

    150+Attendees
    60%Director / VP and Above
    40+Speakers
    200+Meetings Facilitated

    When to use them

    When External Control Arms Are Used

    External controls answer a question a single-arm study cannot on its own. These are the situations where they fit.

    Rare Diseases
    Too few patients to randomize a conventional trial.
    Single-Arm Trials
    No internal comparator arm to judge the effect.
    Ethical Constraints
    When withholding treatment is not acceptable.
    Accelerated Pathways
    Supporting faster regulatory review.
    Feasibility & Cost
    When a full randomized trial is impractical.
    Post-Approval Evidence
    Contextualizing outcomes after launch.

    The distinction

    External vs Randomized Control

    Both give a single-arm trial something to compare against. One is randomized inside the trial; the other is drawn from outside it.

    Randomized (Internal) Control

    • Assigned at random within the trial
    • Removes confounding by design
    • Concurrent with the treatment group
    • Strong internal validity

    External Control

    • Built from real-world or historical data
    • Needs methods to reduce bias
    • May differ in time or setting
    • Broad, representative and feasible

    External controls rely on careful design and methods. See observational studies, comparative effectiveness research and synthetic control arms.

    How it works

    How an External Control Arm Is Built

    A credible external control is built like the trial it emulates, step by step.

    Step 1
    Define the Target TrialThe ideal randomized comparison to emulate.
    Step 2
    Select the Data SourceFit-for-purpose real-world or historical data.
    Step 3
    Match EligibilityApply the trial’s criteria to the data.
    Step 4
    Align Time ZeroA comparable index point for follow-up.
    Step 5
    Adjust for ConfoundingPropensity scores and weighting.
    Step 6
    Compare & ValidateEstimate effects with sensitivity analyses.

    The data

    Data Sources for External Controls

    An external control is only as good as the data behind it. These are the main sources.

    Electronic Health Records
    Clinical depth from routine care.
    Administrative Claims
    Large populations and treatment patterns.
    Disease Registries
    Curated, long-term cohorts.
    Prior Clinical Trials
    Patient-level data from earlier studies.
    Natural History Studies
    Untreated disease progression over time.
    Linked & Tokenized Data
    Connected, longitudinal patient records.

    Getting it right

    Keeping External Controls Credible

    The credibility of an external control rests on how well it matches the trial it stands in for. These are the essentials.

    Comparable Eligibility
    The same inclusion and exclusion criteria as the trial.
    Aligned Time Zero
    A matched index point for starting follow-up.
    Propensity Adjustment
    Balancing measured confounders across groups.
    Consistent Endpoints
    Outcomes defined and measured the same way.
    Sensitivity Analysis
    Testing robustness to unmeasured confounding.
    Transparency & Pre-Registration
    Pre-specify and report methods so results reproduce.

    The direction of travel

    Where External Controls Are Heading in 2026

    External controls are moving from the margins toward the mainstream. These are the shifts to watch, and debates on the agenda at RWE Connect 2026.

    Growing Regulatory Acceptance
    FDA and EMA guidance on external controls evolving.
    Synthetic Control Arms
    Matched, patient-level modeled comparators.
    Target Trial Emulation
    The framing standard for a credible comparison.
    Tokenized & Linked Data
    Richer, longitudinal comparator data.
    Oncology & Rare Disease
    The leading use cases for external controls.
    Transparency Standards
    Pre-specification becoming the norm.

    Who is in the room

    Who Attends RWE Connect 2026

    A senior, focused audience of the people who design trials and build comparators.

    60%Director / VP and Above
    Director / VP and AboveOther senior roles
    RWE & Real-World Data26%
    Clinical, Medical & Regulatory20%
    Epidemiology & Biostatistics18%
    HEOR & Market Access14%
    Data Science & Analytics12%
    Research, Academia & Startups10%

    Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative; confirmed registration splits are shared with sponsors from the live delegate list.

    Sponsor RWE Connect 2026

    Meet the Evidence and Methods Buyers in Boston

    The teams that design trials and build comparators gather at RWE Connect 2026: 150+ attendees, around 60% at Director or VP level and above.

    Reach the BuyersRWE, clinical development, epidemiology and biostatistics leaders who design comparators.
    Pre-Scheduled 1:1 MeetingsName the buyers you want; the Partnering Lounge books the meetings before the doors open.
    Demos and SpeakingShow your data, methods and case studies to the teams who use them.

    RWE Connect 2026

    Get the RWE Study Methods Primer

    A plain-English guide to the core real-world evidence methods, including external control arms. See the methods, then meet the people applying them in Boston.

    • When and how external controls are used
    • How to keep a comparator credible
    • Where the methods are heading in 2026

    Interested in sponsoring? See sponsorship options

    Get the RWE Study Methods Primer
    Instant download. Three fields.










      Free. Instant download. No obligation.

      External Control Arms: Common Questions

      What is an external control arm?

      An external control arm is a comparator group built from real-world or historical data instead of randomization, used to interpret a single-arm trial when a conventional control arm is not feasible or ethical.

      When are external control arms used?

      In rare diseases, single-arm trials, situations where withholding treatment is not ethical, accelerated regulatory pathways, and when a full randomized trial is impractical.

      What is the difference between an external and a synthetic control arm?

      An external control arm draws a comparator from real-world or historical data. A synthetic control arm is a specific type that builds a matched, patient-level comparator, often using statistical matching or modeling.

      How is an external control arm different from a randomized control?

      A randomized control is assigned at random within the same trial, removing confounding by design. An external control is drawn from other data, so it relies on careful matching and methods to reduce bias.

      How is an external control arm built?

      By defining the target trial, selecting fit-for-purpose data, applying the trial’s eligibility criteria, aligning time zero, adjusting for confounding, and comparing outcomes with sensitivity analyses.

      What data is used for external control arms?

      Electronic health records, administrative claims, disease registries, patient-level data from prior trials, natural history studies, and linked or tokenized data.

      How do you control for confounding in an external control arm?

      Through comparable eligibility, aligned time zero, propensity score adjustment, consistent endpoint definitions, and sensitivity analyses for unmeasured confounding.

      Are external control arms accepted by regulators?

      Yes, in appropriate settings, within the FDA and EMA frameworks, when the data and methods are fit for the question. They are most established in oncology and rare disease.

      What is a single-arm trial?

      A single-arm trial gives every participant the treatment, without a randomized comparator, so an external control arm is often used to interpret the results.

      What is natural history data?

      Natural history data describes how a disease progresses without the treatment under study, a valuable source for external comparators.

      What is RWE Connect 2026?

      RWE Connect 2026 is a two-day real-world evidence summit in Boston bringing together the RWE, HEOR and methods leaders who generate and apply real-world evidence, with 40+ speakers and 150+ attendees.

      When and where is RWE Connect 2026?

      14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.

      Join the Movement. Shape the Future.

      Be part of a community that’s redefining how the world measures healthcare impact.

      Join us at RWE Connect 2026
      where data meets decisions.

      Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆Get Your Complimentary Delegate Pass◆